SAKE-YEAST-CONTAINING TABLET
The purpose of this invention is to obtain a tablet that exhibits sufficient tablet properties such as hardness and disintegrability despite having a high content of sake yeast such that said sake yeast produces a sufficient effect. This invention provides a tablet that contains sake yeast and lacto...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GOKITA, TOSHIO MINAMINO, HIDEAKI SUZUKI, KIWAMU KANESHIMA, DAISUKE |
| description | The purpose of this invention is to obtain a tablet that exhibits sufficient tablet properties such as hardness and disintegrability despite having a high content of sake yeast such that said sake yeast produces a sufficient effect. This invention provides a tablet that contains sake yeast and lactose, wherein sake-yeast mass (A) constitutes at least 15% of the mass of the tablet and the mass ratio (B/A) of the amount of lactose (B) in the tablet to the amount of sake-yeast mass (A) in the tablet is greater than or equal to 0.07.
L'invention a pour objectif de fournir un comprimé tel qu'indépendamment d'une teneur élevée en levure de saké de manière à permettre d'en développer suffisamment les effets, les propriétés physiques du comprimé telles que la dureté, les propriétés de désagrégation, ou similaire, sont suffisantes. Ainsi, l'invention concerne un comprimé qui comprend de la levure de saké et un lactose. Plus précisément, l'invention fournit un comprimé qui comprend 15% ou plus de cellules de levure de saké (A) dans un comprimé, et qui présente un rapport massique (B/A) de la teneur en lactose (B) par rapport à la teneur en cellules de levure de saké (A), de 0,07 ou plus.
本発明は、清酒酵母が十分な効果を発揮できるような高い含有量であるにもかかわらず、硬度、崩壊性等の錠剤物性が十分な錠剤を得ることを目的とする。清酒酵母と乳糖とを含有する錠剤において、清酒酵母菌体（Ａ）を錠剤中に１５％以上含有し、清酒酵母菌体（Ａ）の含有量に対する乳糖（Ｂ）の含有量の質量比率（Ｂ／Ａ）が、０．０７以上である錠剤を提供する。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2015190453A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2015190453A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2015190453A13</originalsourceid><addsrcrecordid>eNrjZJAJdvR21Y10dQwO0XX29wtx9PTz9HNXCHF08nEN4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGpoaWBiamxo6GxsSpAgD21iG5</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SAKE-YEAST-CONTAINING TABLET</title><source>esp@cenet</source><creator>GOKITA, TOSHIO ; MINAMINO, HIDEAKI ; SUZUKI, KIWAMU ; KANESHIMA, DAISUKE</creator><creatorcontrib>GOKITA, TOSHIO ; MINAMINO, HIDEAKI ; SUZUKI, KIWAMU ; KANESHIMA, DAISUKE</creatorcontrib><description>The purpose of this invention is to obtain a tablet that exhibits sufficient tablet properties such as hardness and disintegrability despite having a high content of sake yeast such that said sake yeast produces a sufficient effect. This invention provides a tablet that contains sake yeast and lactose, wherein sake-yeast mass (A) constitutes at least 15% of the mass of the tablet and the mass ratio (B/A) of the amount of lactose (B) in the tablet to the amount of sake-yeast mass (A) in the tablet is greater than or equal to 0.07.
L'invention a pour objectif de fournir un comprimé tel qu'indépendamment d'une teneur élevée en levure de saké de manière à permettre d'en développer suffisamment les effets, les propriétés physiques du comprimé telles que la dureté, les propriétés de désagrégation, ou similaire, sont suffisantes. Ainsi, l'invention concerne un comprimé qui comprend de la levure de saké et un lactose. Plus précisément, l'invention fournit un comprimé qui comprend 15% ou plus de cellules de levure de saké (A) dans un comprimé, et qui présente un rapport massique (B/A) de la teneur en lactose (B) par rapport à la teneur en cellules de levure de saké (A), de 0,07 ou plus.
本発明は、清酒酵母が十分な効果を発揮できるような高い含有量であるにもかかわらず、硬度、崩壊性等の錠剤物性が十分な錠剤を得ることを目的とする。清酒酵母と乳糖とを含有する錠剤において、清酒酵母菌体（Ａ）を錠剤中に１５％以上含有し、清酒酵母菌体（Ａ）の含有量に対する乳糖（Ｂ）の含有量の質量比率（Ｂ／Ａ）が、０．０７以上である錠剤を提供する。</description><language>eng ; fre ; jpn</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2015</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151217&DB=EPODOC&CC=WO&NR=2015190453A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151217&DB=EPODOC&CC=WO&NR=2015190453A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GOKITA, TOSHIO</creatorcontrib><creatorcontrib>MINAMINO, HIDEAKI</creatorcontrib><creatorcontrib>SUZUKI, KIWAMU</creatorcontrib><creatorcontrib>KANESHIMA, DAISUKE</creatorcontrib><title>SAKE-YEAST-CONTAINING TABLET</title><description>The purpose of this invention is to obtain a tablet that exhibits sufficient tablet properties such as hardness and disintegrability despite having a high content of sake yeast such that said sake yeast produces a sufficient effect. This invention provides a tablet that contains sake yeast and lactose, wherein sake-yeast mass (A) constitutes at least 15% of the mass of the tablet and the mass ratio (B/A) of the amount of lactose (B) in the tablet to the amount of sake-yeast mass (A) in the tablet is greater than or equal to 0.07.
L'invention a pour objectif de fournir un comprimé tel qu'indépendamment d'une teneur élevée en levure de saké de manière à permettre d'en développer suffisamment les effets, les propriétés physiques du comprimé telles que la dureté, les propriétés de désagrégation, ou similaire, sont suffisantes. Ainsi, l'invention concerne un comprimé qui comprend de la levure de saké et un lactose. Plus précisément, l'invention fournit un comprimé qui comprend 15% ou plus de cellules de levure de saké (A) dans un comprimé, et qui présente un rapport massique (B/A) de la teneur en lactose (B) par rapport à la teneur en cellules de levure de saké (A), de 0,07 ou plus.
本発明は、清酒酵母が十分な効果を発揮できるような高い含有量であるにもかかわらず、硬度、崩壊性等の錠剤物性が十分な錠剤を得ることを目的とする。清酒酵母と乳糖とを含有する錠剤において、清酒酵母菌体（Ａ）を錠剤中に１５％以上含有し、清酒酵母菌体（Ａ）の含有量に対する乳糖（Ｂ）の含有量の質量比率（Ｂ／Ａ）が、０．０７以上である錠剤を提供する。</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2015</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJdvR21Y10dQwO0XX29wtx9PTz9HNXCHF08nEN4WFgTUvMKU7lhdLcDMpuriHOHrqpBfnxqcUFicmpeakl8eH-RgaGpoaWBiamxo6GxsSpAgD21iG5</recordid><startdate>20151217</startdate><enddate>20151217</enddate><creator>GOKITA, TOSHIO</creator><creator>MINAMINO, HIDEAKI</creator><creator>SUZUKI, KIWAMU</creator><creator>KANESHIMA, DAISUKE</creator><scope>EVB</scope></search><sort><creationdate>20151217</creationdate><title>SAKE-YEAST-CONTAINING TABLET</title><author>GOKITA, TOSHIO ; MINAMINO, HIDEAKI ; SUZUKI, KIWAMU ; KANESHIMA, DAISUKE</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2015190453A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; jpn</language><creationdate>2015</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GOKITA, TOSHIO</creatorcontrib><creatorcontrib>MINAMINO, HIDEAKI</creatorcontrib><creatorcontrib>SUZUKI, KIWAMU</creatorcontrib><creatorcontrib>KANESHIMA, DAISUKE</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GOKITA, TOSHIO</au><au>MINAMINO, HIDEAKI</au><au>SUZUKI, KIWAMU</au><au>KANESHIMA, DAISUKE</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SAKE-YEAST-CONTAINING TABLET</title><date>2015-12-17</date><risdate>2015</risdate><abstract>The purpose of this invention is to obtain a tablet that exhibits sufficient tablet properties such as hardness and disintegrability despite having a high content of sake yeast such that said sake yeast produces a sufficient effect. This invention provides a tablet that contains sake yeast and lactose, wherein sake-yeast mass (A) constitutes at least 15% of the mass of the tablet and the mass ratio (B/A) of the amount of lactose (B) in the tablet to the amount of sake-yeast mass (A) in the tablet is greater than or equal to 0.07.
L'invention a pour objectif de fournir un comprimé tel qu'indépendamment d'une teneur élevée en levure de saké de manière à permettre d'en développer suffisamment les effets, les propriétés physiques du comprimé telles que la dureté, les propriétés de désagrégation, ou similaire, sont suffisantes. Ainsi, l'invention concerne un comprimé qui comprend de la levure de saké et un lactose. Plus précisément, l'invention fournit un comprimé qui comprend 15% ou plus de cellules de levure de saké (A) dans un comprimé, et qui présente un rapport massique (B/A) de la teneur en lactose (B) par rapport à la teneur en cellules de levure de saké (A), de 0,07 ou plus.
本発明は、清酒酵母が十分な効果を発揮できるような高い含有量であるにもかかわらず、硬度、崩壊性等の錠剤物性が十分な錠剤を得ることを目的とする。清酒酵母と乳糖とを含有する錠剤において、清酒酵母菌体（Ａ）を錠剤中に１５％以上含有し、清酒酵母菌体（Ａ）の含有量に対する乳糖（Ｂ）の含有量の質量比率（Ｂ／Ａ）が、０．０７以上である錠剤を提供する。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; jpn |
| recordid | cdi_epo_espacenet_WO2015190453A1 |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | SAKE-YEAST-CONTAINING TABLET |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A58%3A29IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GOKITA,%20TOSHIO&rft.date=2015-12-17&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2015190453A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |